3,5-dihydroxyphenylglycine has been researched along with bradykinin in 1 studies
| Studies (3,5-dihydroxyphenylglycine) | Trials (3,5-dihydroxyphenylglycine) | Recent Studies (post-2010) (3,5-dihydroxyphenylglycine) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
|---|---|---|---|---|---|
| 301 | 1 | 61 | 14,195 | 355 | 1,520 |
| Protein | Taxonomy | 3,5-dihydroxyphenylglycine (IC50) | bradykinin (IC50) |
|---|---|---|---|
| B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Cheng, HP; Guo, C; Sun, Q; Tang, TS; Wang, JQ; Wang, QC; Wang, X; Wang, Y | 1 |
1 other study(ies) available for 3,5-dihydroxyphenylglycine and bradykinin
| Article | Year |
|---|---|
Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease.
Topics: Animals; Bradykinin; Calcium; Calcium Channels; Calcium Signaling; DNA Damage; DNA, Mitochondrial; Embryo, Mammalian; Female; Fibroblasts; Genome, Mitochondrial; Glycine; Humans; Huntington Disease; Inositol 1,4,5-Trisphosphate Receptors; Mice; Mice, Transgenic; Mitochondria; Neostriatum; Neurons; Resorcinols; Superoxides | 2013 |